Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
5.
Perfusion ; 27(3): 225-9, 2012 May.
Article in English | MEDLINE | ID: mdl-22249964

ABSTRACT

Extracorporeal membrane oxygenation (ECMO) has emerged as an effective mechanical support following cardiac surgery with respiratory and cardiac failure. However, there are no clear indications for ECMO use after pediatric cardiac surgery. We retrospectively reviewed medical records of 76 pediatric patients [mean age, 10.8 months (0-86); mean weight, 5.16 kg (1.16-16.5)] with congenital heart disease who received ECMO following cardiac surgery between January 1997 and October 2010. Forty-five patients were treated with an aggressive ECMO approach (aggressive ECMO group, April 2005-October 2010) and 31 with a delayed ECMO approach (delayed ECMO group, January 1997-March 2005). Demographics, diagnosis, operative variables, ECMO indication, and duration of survivors and non-survivors were compared. Thirty-four patients (75.5%) were successfully weaned from ECMO in the aggressive ECMO group and 26 (57.7%) were discharged. Conversely, eight patients (25.8%) were successfully weaned from ECMO in the delayed ECMO group and two (6.5%) were discharged. Forty-five patients with shunted single ventricle physiology (aggressive: 29 patients, delayed: 16 patients) received ECMO, but only 15 (33.3%) survived and were discharged. The survival rate of the aggressive ECMO group was significantly better when compared with the delayed ECMO group (p<0.01). Also, ECMO duration was significantly shorter among the aggressive ECMO group survivors (96.5 ± 62.9 h, p<0.01). Thus, the aggressive ECMO approach is a superior strategy compared to the delayed ECMO approach in pediatric cardiac patients. The aggressive ECMO approach improved our outcomes of neonatal and pediatric ECMO.


Subject(s)
Cardiac Surgical Procedures , Extracorporeal Membrane Oxygenation/methods , Heart Defects, Congenital/surgery , Child , Child, Preschool , Disease-Free Survival , Extracorporeal Membrane Oxygenation/adverse effects , Female , Heart Defects, Congenital/mortality , Humans , Infant , Infant, Newborn , Male , Retrospective Studies , Survival Rate
6.
Arch Dis Child Fetal Neonatal Ed ; 88(2): F128-33, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12598502

ABSTRACT

BACKGROUND: Infants requiring extracorporeal membrane oxygenation (ECMO) support represent a high risk group in terms of cerebral injury. Mild hypothermia both during and after cerebral hypoxic ischaemia appears to be a promising strategy for offering neuroprotection. OBJECTIVE: To investigate whether mild hypothermia was both feasible and safe in infants receiving ECMO as a prelude to any formal assessment of this approach in a randomised trial. METHODS: Twenty infants (body weight less than 5 kg) with severe cardiopulmonary insufficiency, referred for ECMO support at Glenfield Hospital, Leicester, were enrolled in this study. Twenty consecutive infants (compromising four groups of five) were studied. Baseline data were obtained from a control group who were run throughout their course at 37 degrees C. The patients in the next group were managed with a core temperature of 36 degrees C for the first 12 hours of their ECMO run, before being warmed up to 37 degrees C. After successful completion, the next group of five were cared for at 35 degrees C for the first 12 hours, and, there having been no previous complications, the final group were cared for at 34 degrees C for the first 12 hours. Patients were assessed clinically and biologically. In addition to routine laboratory tests, cytokines (interleukin 6, interleukin 8, tumour necrosis factor alpha, and C reactive protein) were measured and coagulation tests (D-dimer, thrombin-antithrombin III complex, plasmin-alpha(2)-antiplasmin complex) were performed serially for five days. RESULTS: There were no significant differences among the four groups in gestational age, birth weight, age at the time of ECMO, Apgar scores at one and five minutes, pH before cannulation, oxygenation index, duration of ECMO, and survival rate to discharge from hospital. No adverse effects of mild hypothermia were found on patient management during ECMO. Laboratory data for up to five days of ECMO also showed no difference among the four groups. CONCLUSION: Mild hypothermia (34 degrees C) for the initial 12 hours of an ECMO run is feasible.


Subject(s)
Extracorporeal Membrane Oxygenation/methods , Hypothermia, Induced/methods , Respiratory Insufficiency/therapy , Blood Cell Count , Blood Specimen Collection/methods , Body Temperature , Feasibility Studies , Hemodynamics , Hospital Mortality , Humans , Hypothermia, Induced/adverse effects , Infant, Newborn , Kidney/physiopathology , Liver/physiopathology , Pilot Projects , Respiratory Insufficiency/physiopathology , Survival Rate , Treatment Outcome
7.
Kyobu Geka ; 53(8 Suppl): 702-5, 2000 Jul.
Article in Japanese | MEDLINE | ID: mdl-10935391

ABSTRACT

Three cases of pulmonary mucoepidermoid carcinoma, which were surgically treated in our hospital, were reported. The first case was 28-year-old male, who had hemoptysis, underwent right upper lobectomy and mediastinal lymph node dissection on October 31, 1973. The tumor located and obstructed the ostium of right B2. The diameter was 2.3 x 1.8 cm. The second case was 63-year-old male, who had obstructive pneumonia, underwent left upper lobectomy and mediastinal lymph node dissection on November 18, 1998. The tumor located and obstructed the ostium of lingular bronchus, and the diameter was 1.8 x 1.2 cm. The third case was 25-year-old male, who had obstructive pneumonia, underwent left sleeve lower lobectomy and mediastinal lymph node dissection on May 26, 1999. The tumor located in ostium of left B6, and it obstructed lower bronchus and expanded into the lung. The diameter was 4 x 2 cm. All cases were diagnosed as low grade malignancy with no lymph node metastasis. The first case survived without recurrence at least 5 years as far as we followed, and the others are surviving until now without any signs of recurrence. These three cases were 0.19% of total resected lung cancers in our hospital from 1969 to 1999.


Subject(s)
Carcinoma, Mucoepidermoid/surgery , Lung Neoplasms/surgery , Adult , Humans , Lymph Node Excision , Male , Middle Aged , Pneumonectomy/methods , Treatment Outcome
8.
Ann Thorac Surg ; 69(1): 298-9, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10654547

ABSTRACT

Lung rest is the primary goal of venovenous extracorporeal membrane oxygenation for severe acute respiratory failure. To achieve this there has to be adequate extracorporeal flow. This can be achieved by a two-cannula technique in most cases. In some cases, extra flow is either not achievable or causes excessive recirculation. We report 8 patients in whom we achieved adequate blood and oxygen delivery using a three-cannula technique. Five patients survived (62.5%).


Subject(s)
Extracorporeal Membrane Oxygenation/instrumentation , Acute Disease , Adult , Blood Circulation/physiology , Cardiac Catheterization/instrumentation , Catheterization/instrumentation , Catheterization, Peripheral/instrumentation , Equipment Design , Extracorporeal Membrane Oxygenation/methods , Female , Humans , Lung/physiology , Male , Oxygen/blood , Pulmonary Gas Exchange/physiology , Respiration, Artificial , Respiratory Insufficiency/therapy , Survival Rate
9.
ASAIO J ; 45(5): 478-81, 1999.
Article in English | MEDLINE | ID: mdl-10503629

ABSTRACT

Blood flow is believed to affect the thrombogenicity of extracorporeal circulation (ECC). The purpose of this study was to look at the relationship between blood flow and thrombogenicity in a rabbit model of ECC. Rabbits were anesthetized and systematically heparinized. Bilateral jugular cannulation was performed, and the animals were placed on venovenous ECC. The circuits were composed of 1 m of 1/4 inch size surgical grade polyvinylchloride (PVC) tubing. ECC was maintained for 4 hours. Three experimental groups were studied: a high flow group (n=7; flow rate: 30 ml/min/Kg), low flow group (n=7; flow rate: 10 ml/mg/Kg), and no ECC group (n=7). Platelet count, fibrinogen concentration, PaO2/FiO2, and postmortem findings were evaluated. Platelet consumption was higher with high flow, and fibrinogen consumption was higher with low flow.


Subject(s)
Extracorporeal Circulation , Thrombosis/etiology , Animals , Blood Flow Velocity , Fibrinogen/metabolism , Platelet Activation , Platelet Adhesiveness , Rabbits
10.
Ann Thorac Surg ; 67(2): 332-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10197650

ABSTRACT

BACKGROUND: This study was designed to investigate the efficacy of partial liquid ventilation (PLV) on acute allograft dysfunction after lung transplantation. METHODS: The canine left lung allotransplantation model was used, with the graft preserved in 4 degrees C low-potassium dextran glucose solution for 18 hours. The control group (n = 6) had conventional mechanical ventilation, and the PLV group (n = 6) had perfluorooctylbromide instilled into the airway 30 minutes after reperfusion. For 360 minutes, allograft function and hemodynamics were evaluated. After the evaluation, myeloperoxidase activity of the graft tissue was assayed. RESULTS: All dogs survived for 360 minutes. In the PLV group, PaO2, shunt fraction, and alveolar to arterial gradient for O2 were significantly better than those in the control group after 120, 180, and 120 minutes, respectively (p < 0.05). After 240 minutes, peak airway pressure became significantly lower than that in the control group (p < 0.05). The PaO2 at 360 minutes was 102 +/- 55 mm Hg in the control group and 420 +/- 78 mm Hg in the PLV group (p < 0.0001), and the peak airway pressure was 21.4 +/- 4.1 mm Hg in the control group and 14.7 +/- 5.0 mm Hg in the PLV group (p < 0.05). Myeloperoxidase activity in the PLV group was lower than that in the control group. CONCLUSIONS: The study shows that PLV alleviated acute allograft dysfunction after lung transplantation.


Subject(s)
Fluorocarbons , Lung Transplantation/physiology , Lung/blood supply , Reperfusion Injury/therapy , Respiration, Artificial , Animals , Dogs , Fluorocarbons/administration & dosage , Hydrocarbons, Brominated , Lung/pathology , Lung Transplantation/pathology , Oxygen/blood , Pulmonary Gas Exchange/physiology , Reperfusion Injury/pathology , Reperfusion Injury/physiopathology , Transplantation, Homologous
12.
J Thorac Cardiovasc Surg ; 116(2): 262-6, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9699578

ABSTRACT

OBJECTIVE: Tracheal reconstruction is necessary in patients with extensive tracheal stenosis caused by neoplasm, trauma, and congenital disease. We investigated the possibility of tracheal allotransplantation with cryopreserved grafts in a canine model. METHODS: A seven-ring section of thoracic trachea was removed in 19 adult mongrel dogs. In group A (n = 4), a five-ring tracheal autograft was implanted. In group B (n = 6), a five-ring allograft was implanted without immunosuppression. In group C (n = 9), a five-ring cryopreserved tracheal allograft was implanted without immunosuppression. Omentopexy wrapping around the grafts and both anastomotic sites was used in all animals. RESULTS: All grafts survived without any evidence of atrophy or stenosis in group A. All animals in group B died of severe airway obstruction within 1 month, and postmortem examination of these grafts showed epithelial defect and necrotic tracheal cartilage in the scar tissue. In group C, no animals died of asphyxia caused by severe stenosis of the grafts. The graft epithelium was no longer present 20 days after transplantation, and the graft was covered with regenerated epithelium within about 60 days after the operation. CONCLUSION: These findings show that cryopreserved tracheal allografts can be transplanted by means of omentopexy without immunosuppression and that cryopreservation may reduce tracheal allogenicity.


Subject(s)
Cryopreservation , Trachea/transplantation , Animals , Dogs , Epithelial Cells/cytology , Follow-Up Studies , Graft Survival/physiology , Trachea/cytology , Trachea/physiology , Transplantation, Homologous , Wound Healing
13.
Acta Med Okayama ; 52(3): 131-7, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9661739

ABSTRACT

To study the effect of partial liquid ventilation (PLV) with perfluorocarbon on acute respiratory failure, 3 groups of 17 rabbits were examined to compare. After acute respiratory failure was induced by lung lavage with sea water in 12 of the 17 rabbits, 7 of the 12 rabbits were treated with conventional mechanical ventilation (AC group) and 5 of the 12 rabbits were treated with PLV using perfluorocarbon (AP group). The remaining 5 normal rabbits without acute respiratory failure were treated with PLV with perfluorocarbon as a control group (PL group). In the PL group, PaO2, PaCO2, blood pH, pulmonary compliance or pathological findings were not so changed after PLV. In the AC and AP groups, PaCO2 significantly increased, and in contrast, PaO2 and pulmonary compliance significantly decreased after lung lavage. However, these findings improved to almost the same levels as those of a control group within 2 h after the PLV treatment in the AP group, but in the AC group, these gradually deteriorated over time. As for the pathological findings, pulmonary vascular congestion, alveolar hemorrhage and inflammatory infiltration were observed in the AC group. However, these findings were not observed in the specimens of the AP group. From these results, PLV with perfluorocarbon was shown to be useful to improve gas exchange and pulmonary functions without major side effects.


Subject(s)
Bronchoalveolar Lavage/methods , Pulmonary Ventilation , Respiratory Insufficiency/therapy , Seawater , Acute Disease , Animals , Carbon Dioxide/metabolism , Hydrogen-Ion Concentration , Lung Compliance , Oxygen/metabolism , Partial Pressure , Rabbits , Respiratory Insufficiency/etiology
14.
Nihon Kyobu Geka Gakkai Zasshi ; 45(7): 964-9, 1997 Jul.
Article in Japanese | MEDLINE | ID: mdl-9256632

ABSTRACT

In this study, we investigated whether the regenerated epithelia were recipient phenotype or donor phenotype using PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) method. Preoperatively 24 mongrel dogs were classified to 14 types by PCR-RFLP result from peripheral blood. The PCR-RFLP result of peripheral blood agreed to that of recipient epithelia. The cryopreserved tracheal allotransplantation was performed among the five pairs in which we could distinguish donor from recipient by PCR-RFLP. The epithelia of graft at 10 days after transplantation showed donor phenotype, but the epithelia at postoperative 20 days or more showed recipient phenotype. These results showed that allogenic epithelium remained in early post-transplant time and was gradually omitted. The epithelia migrated gradually from the anastomotic site, and the graft was covered with regenerated epithelia showing recipient phenotype within about 50 post-transplant days.


Subject(s)
Cryopreservation , Polymorphism, Restriction Fragment Length , Trachea , Trachea/transplantation , Animals , Dogs , Epithelium , Female , Male , Necrosis , Polymerase Chain Reaction , Trachea/pathology , Transplantation, Homologous
16.
Artif Organs ; 20(2): 120-3, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8712954

ABSTRACT

Extracorporeal membrane oxygenation (ECMO) for respiratory failure was reviewed. ECMO progressed from laboratory research to initial clinical trials in 1972. Following a decade of clinical research, ECMO is now standard treatment for neonatal respiratory failure refractory to conventional pulmonary support techniques worldwide. The application of neonatal ECMO has been extended with improved outcome to premature and low birth weight infants as well as older children and adults. As of July 1994, 9,258 neonates, 754 pediatric, and 130 adult patients with respiratory failure treated with ECMO were entered in the registry of the Extracorporeal Life Support Organization (ELSO). Overall survival rates were 81% in neonates, 49% in pediatric, and 38% in adult patients. Recently the adult and pediatric populations treated with ECMO have increased rapidly, and the outcome has improved significantly.


Subject(s)
Extracorporeal Membrane Oxygenation/standards , Respiratory Insufficiency/therapy , Adolescent , Adult , Child , Child, Preschool , Extracorporeal Membrane Oxygenation/trends , Humans , Infant, Newborn , Infant, Premature, Diseases/mortality , Infant, Premature, Diseases/therapy , Respiratory Distress Syndrome, Newborn/mortality , Respiratory Distress Syndrome, Newborn/therapy , Respiratory Insufficiency/mortality , Treatment Outcome
17.
Rinsho Ketsueki ; 35(11): 1315-21, 1994 Nov.
Article in Japanese | MEDLINE | ID: mdl-7529843

ABSTRACT

In February, 1990, a 49-year-old man was admitted with petechia and gingival bleeding. The peripheral blood showed 5,200 leukocytes/microliters including 73% abnormal promyelocytes and 24,000/microliters platelets. Bone marrow puncture revealed that nucleated cell count was 331,250/microliters including 85.4% abnormal promyelocytes with 46XY, i(17q) chromosome. Coagulation tests revealed DIC. He was diagnosed as having acute promyelocytic leukemia, and he was treated with the BHAC-DMP protocol. He achieved complete remission, and received consolidation therapy and maintenance therapy. However, he relapsed in May, 1991 with 46XY, 16q-, i (17q) chromosome. He was treated with BHAC-MV protocol and again achieved complete remission. In June, 1992, he re-relapsed and 3.6% blasts and 10% abnormal promyelocytes was found in his bone marrow. He was treated for 14 days with 15 mg Aclarubicin without any change. Then he was treated with 60 mg All-trans retinoic acid (ATRA). After administration of ATRA, his peripheral blood leukocyte count increased temporarily but bone marrow suppression continued. Then he received continuous subcutaneous infusion of 24 micrograms/day granulocyte colony-stimulating factor (rhG-CSF). After treatment with ATRA and rhG-CSF, he entered a third complete remission.


Subject(s)
Granulocyte Colony-Stimulating Factor/therapeutic use , Leukemia, Promyelocytic, Acute/therapy , Tretinoin/therapeutic use , Combined Modality Therapy , Humans , Leukemia, Promyelocytic, Acute/drug therapy , Male , Middle Aged , Recurrence , Remission Induction
19.
Acta Med Okayama ; 46(3): 213-21, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1502926

ABSTRACT

Extracorporeal Membrane Oxygenation (ECMO) has been adopted as a means of strong respiratory support. In lung transplantation, reimplantation response is still a serious problem. It causes severe respiratory failure which is refractory to mechanical ventilation in some cases. The purpose of this study was to evaluate the effects of veno-venous ECMO after lung transplantation using a canine autotransplantation model. The autotransplantation model was created by keeping the left lung in a warm ischemic state for 2 h. After reperfusion, the right pulmonary artery was ligated. The following two groups were studied: Group 1, Control group, (no ECMO group) (n = 6). After reperfusion, both lungs were ventilated without ECMO. Group 2, ECMO group (n = 7). After reperfusion, veno-venous ECMO support was introduced with reduction of mechanical ventilation. In the no ECMO group, four of the animals died within 210 min after reperfusion. In the ECMO group, two of the animals died of severe pulmonary edema. Data of blood gas analyses (PaO2, PaCO2, and SvO2) after reperfusion were significantly better in the ECMO group, whereas there were no significant differences in both shunt fraction and pulmonary vascular resistance index. In this model with severe pulmonary edema induced by warm ischemia, veno-venous ECMO contributed to the improvement of hypoxemia and hypercapnia, but did not improve pulmonary hemodynamics.


Subject(s)
Extracorporeal Membrane Oxygenation , Lung Transplantation/adverse effects , Respiratory Insufficiency/therapy , Animals , Carbon Dioxide/blood , Dogs , Hemodynamics , Lung Transplantation/mortality , Oxygen/blood , Respiratory Insufficiency/physiopathology
20.
Kyobu Geka ; 45(5): 379-83; discussion 384-6, 1992 May.
Article in Japanese | MEDLINE | ID: mdl-1593804

ABSTRACT

A clinical study was conducted of 17 patients aged less than 40 years who received resection for lung cancer in our department. The 17 cases made up 1.8% of the total series of 924 resected lung cancer cases, with the number of cases increasing as the age of 40 years was approached. The male-female ratio was 1.1:1, with proportion of women higher than in the total series of lung cancer cases. The histological type of included a high proportion of adenocarcinomas (47.0%), while squamous cell carcinomas were few. In addition, the proportion of tumors of low-grade malignancy such as carcinoid tumors and mucoepidermoid carcinomas was high. The majority (58.8%) of cases were detected by mass screening. As a result, the number of stage I cases was high (10 cases, 58.8%), and curative resection could be performed in 70.8%. The prognosis of these young patients did not differ significantly from that of the total resected group, with a 5-year survival rate of 62.4% achieved. It was considered that the prognosis of lung cancer in young persons can also be improved with early detection by mass screening and active surgical intervention.


Subject(s)
Lung Neoplasms/surgery , Adenocarcinoma/mortality , Adenocarcinoma/surgery , Adult , Female , Humans , Lung Neoplasms/mortality , Male , Pneumonectomy , Prognosis , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...